FDA accepts SpringWorks' application for mirdametinib for NF1-PN
FDA accepts SpringWorks’ application for mirdametinib for NF1-PN Source: Seekingalpha
THE HELITRA EDIT
Heltra: Explore Life – Discover More – Live Better
FDA accepts SpringWorks’ application for mirdametinib for NF1-PN Source: Seekingalpha